334 related articles for article (PubMed ID: 28730707)
21. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
[TBL] [Abstract][Full Text] [Related]
22. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract][Full Text] [Related]
23. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
24. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
[TBL] [Abstract][Full Text] [Related]
26. A novel orthotopic mouse model replicates human lung cancer cachexia.
van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
[TBL] [Abstract][Full Text] [Related]
27. Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start?
Hildebrandt W; Keck J; Schmich S; Bonaterra GA; Wilhelm B; Schwarzbach H; Eva A; Bertoune M; Slater EP; Fendrich V; Kinscherf R
Cells; 2022 May; 11(10):. PubMed ID: 35626644
[TBL] [Abstract][Full Text] [Related]
28. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer-induced cachexia is Jak2-dependent in mice.
Gilabert M; Calvo E; Airoldi A; Hamidi T; Moutardier V; Turrini O; Iovanna J
J Cell Physiol; 2014 Oct; 229(10):1437-43. PubMed ID: 24648112
[TBL] [Abstract][Full Text] [Related]
30. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
[TBL] [Abstract][Full Text] [Related]
31. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
[TBL] [Abstract][Full Text] [Related]
32. Modeling Human Cancer-induced Cachexia.
Talbert EE; Cuitiño MC; Ladner KJ; Rajasekerea PV; Siebert M; Shakya R; Leone GW; Ostrowski MC; Paleo B; Weisleder N; Reiser PJ; Webb A; Timmers CD; Eiferman DS; Evans DC; Dillhoff ME; Schmidt CR; Guttridge DC
Cell Rep; 2019 Aug; 28(6):1612-1622.e4. PubMed ID: 31390573
[TBL] [Abstract][Full Text] [Related]
33. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
[TBL] [Abstract][Full Text] [Related]
34. Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.
Nosacka RL; Delitto AE; Delitto D; Patel R; Judge SM; Trevino JG; Judge AR
J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):820-837. PubMed ID: 32039571
[TBL] [Abstract][Full Text] [Related]
35. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.
Winnard PT; Bharti SK; Sharma RK; Krishnamachary B; Mironchik Y; Penet MF; Goggins MG; Maitra A; Kamel I; Horton KM; Jacobs MA; Bhujwalla ZM
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1487-1500. PubMed ID: 33006443
[TBL] [Abstract][Full Text] [Related]
36. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice.
Kliewer KL; Ke JY; Tian M; Cole RM; Andridge RR; Belury MA
Cancer Biol Ther; 2015; 16(6):886-97. PubMed ID: 25457061
[TBL] [Abstract][Full Text] [Related]
37. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
[TBL] [Abstract][Full Text] [Related]
38. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
39. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice.
Delvecchio FR; Fincham REA; Spear S; Clear A; Roy-Luzarraga M; Balkwill FR; Gribben JG; Bombardieri M; Hodivala-Dilke K; Capasso M; Kocher HM
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1543-1565. PubMed ID: 34252585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
